Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazax pharmacodynamics in grass pollen allergy
NCT00773240Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Apr 2008
- Primary completion
- Oct 2008
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of grass-pollen extract in Seasonal Allergic Rhinoconjunctivitis (SAR), sponsored by ALK-Abelló. Started Apr 2008; status: completed.
02
Drugs
grass-pollen extract
03
Conditions
Seasonal Allergic Rhinoconjunctivitis (SAR)
Beyond the preview
Go deeper on NCT00773240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773240.